[Induce treatment of recombinant interferon alpha-1b for chronic hepatitis B and its therapeutic efficiency].
Xu
Zhengju
Z
Clinical liver diseases research center of Nanjing Military command, 180th Hospital of PLA, Quanzhou 362000, China.
Wang
Chongguo
C
Li Sq
Shuqing
S
Huang Yq
Yiqun
Y
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D016896:Treatment Outcome
D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins; C000621575:interferon alfa-1b, human; D000410:Alanine Transaminase